人血白蛋白临床应用管理中国专家共识  

Expert consensus on clinical application management of human albumin

作　　者：中国药学会医院药学专业委员会 《人血白蛋白临床应用管理中国专家共识》编写组 张玉[2] Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association;Compilation Group of Chinese Expert Consensus on Clinical Application Management of Human Albumin

机构地区：[1]不详 [2]华中科技大学同济医学院附属协和医院,湖北省重大疾病精准用药临床医学研究中心,武汉430022

出　　处：《中国医院药学杂志》2024年第7期739-751,共13页Chinese Journal of Hospital Pharmacy

基　　金：国家重点研发计划(编号:2023YFF1205003)。

摘　　要：人血白蛋白是从健康人的血液中提取分离的一种血液制品,在临床救治危急、重症患者中广泛应用。人血白蛋白临床超药品说明书用药及不合理用药现象均较为普遍,药物资源严重浪费。目前我国缺乏权威的指南或共识规范人血白蛋白临床应用管理。为了规范人血白蛋白合理用药管理措施,为人血白蛋白的临床合理应用提供指导,中国药学会医院药学专业委员会组织多学科专家,围绕供应管理、制订临床应用标准、超药品说明书用药管理、合理用药培训、处方环节管理、处方点评管理、信息化管理、患者用药科普等8个方面制订本共识。Derived from healthy human blood,human albumin is widely applied for treating critically and seriously ill patients.However,inappropriate off-label and irrational use of human albumin has remained prevalent,resulting in significant wasting of valuable drug resources.Currently,there is an acute dearth of authoritative guidelines or consensus on clinical application management of human albumin in China.To address this wide gap,a multidisciplinary panel of experts,under the auspices of Committee of Hospital Pharmacy of Chinese Pharmaceutical Association,has collaborated on developing a comprehensive consensus for standardizing management measures and providing guidance for rational utilization of human albumin.This consensus focused upon eight major aspects of clinical application management,including supply management,formulating clinical application standards,management of off-label drug use,training in rational usage,management of prescription sessions,prescription review processes,informatization management and patient education regarding medication usage.

关 键 词：人血白蛋白 合理应用 专家共识 

分 类 号：R95[医药卫生—药学]